Headlines

Medtronic Plc (MDT) Q3 2025 (USD): Adj. EPS 1.36 (exp. 1.34), Revenue 9.00bln (exp. 8.91bln), sees FY Adj. EPS between 5.62-5.66 (exp. 5.65)

Newsquawk Staff ·

Medtronic Plc (MDT) Q3 2025 (USD): Adj. EPS 1.36 (exp. 1.34), Revenue 9.00bln (exp. 8.91bln), sees FY Adj. EPS between 5.62-5.66 (exp. 5.65)

What it means

Medtronic's Q3 results exceeded expectations on both adjusted EPS and revenue, indicating stronger-than-anticipated operational performance. Additionally, the guidance for FY adjusted EPS is in line with consensus, reflecting confidence in ongoing growth amid the healthcare landscape. This solid performance could bolster investor sentiment toward Medtronic and the healthcare sector, particularly if market participants view these results as a confirmation of a positive trend in earnings.

Related headlines